Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Contact Research Site Directly
Pasadena California 91105

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

UPDATED

Contact Research Site Directly
Pasadena California 91105

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Pasadena California 91105

Do you have a fatty liver? Maybe it’s time to consider a different path.

View More ▼

Rialto California 92377

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Colorado

UPDATED

Contact Research Site Directly
Englewood Colorado 80113

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

UPDATED

Contact Research Site Directly
Englewood Colorado 80113

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Englewood Colorado 80113

Do you have a fatty liver? Maybe it’s time to consider a different path.

View More ▼

Englewood Colorado 80113

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Florida

UPDATED

Contact Research Site Directly
Wellington Florida 33414

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

UPDATED

Contact Research Site Directly
Wellington Florida 33414

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Wellington Florida 33414

Do you have a fatty liver? Maybe it’s time to consider a different path.

View More ▼

Tampa Florida

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Wellington Florida 33414

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Magnetic Resonance Imaging (MRI) for patients with Non-alcoholic Fatty Liver Disease

Maryland

Baltimore Maryland 21202

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Massachusetts

Boston Massachusetts 02115

A clinical research study of Lovaza (omega-3-acid ethyl ester) and corn oil for the treatment of Liver Disease or Short Bowel Syndrome

Boston Massachusetts

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

New York

Research Site
Additional Locations New York

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

Biomedical Research Alliance of New York
Manhasset New York 11030

Non-Alcoholic Steatohepatitis (NASH) cirrhosis

View More ▼

New York New York

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

North Carolina

Wake Research Associates
Raleigh North Carolina 27612

Fatty Liver (Nonalcoholic Steatohepatitis - NASH)

View More ▼

Statesville North Carolina 28677

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Ohio

Canton Ohio

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Cleveland Ohio 44106

Patients are needed to participate in a clinical research study evaluating Solithromycin for the treatment of Nonalcoholic Steatohepatitis without Cirrhosis

South Carolina

PMG Research of Charleston
Charleston South Carolina 29464

Nonalcoholic Fatty Liver Disease (NAFLD)

Tennessee

UPDATED

Contact Research Site Directly
Chattanooga Tennessee 37421

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

UPDATED

Contact Research Site Directly
Chattanooga Tennessee 37421

A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults with Nonalcoholic Steatohepatitis (NASH)

Research Center
Chattanooga Tennessee 37421

Do you have a fatty liver? Maybe it’s time to consider a different path.

ClinSearch, LLC
Chattanooga Tennessee 37421

NASH (Nonalcoholic Steatohepatitis)

View More ▼

Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Nashville Tennessee 37211

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Texas

Austin Texas 78756

Patients are needed to participate in a clinical research study evaluating SHP626 and Placebo for the treatment of Non-Alcoholic Steatohepatitis

Dallas Texas 75390-8887

Patients are needed to participate in a clinical research study of Eltrombopag to evaluate Thrombocytopenia or Hepatitis C

Utah

Salt Lake City Utah

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Germany

Mainz Rhineland-Palatine

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Korea, Republic of

Seoul

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Singapore

Singapore

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Spain

Barcelona

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Turkey

Ankara

Patients are needed to participate in a clinical research study for the treatment of Cholesteryl Ester Storage Disease

United Kingdom

London

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Wirral

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma